Resource Center

Stories

The IRE Resource Center is a major research library containing more than 23,250 investigative stories — both print and broadcast.

These stories are searchable online or by contacting the Resource Center directly (573-882-3364 or rescntr@ire.org) where a researcher can help you pinpoint what you need.

Browse or search the tipsheet section of our library below. Stories are not available for download but can be easily ordered by contacting the Resource Center:



Search results for "Paxil" ...

  • Side Effects

    Side Effects tells the story of a court case and the personal story that surrounded the making and unmasking of a bestselling drug, Paxil. "It chronicles the lives of two women - a prosecutor and a whistleblower - who exposes the pattern of deception in the research and marketing of Paxil, an antidepressant prescribed to millions of children and adults."

    Tags: Paxil; FDA; side-effects; GlaxoSmithKline; drug regulators; drug regulation; depression in children; clinical trials; misappropriation;

    By Alison Bass

    5280 (Denver)

    2008

  • Kids, Antidepressants, and Money

    This series uncovered how Texas was medicating foster children with powerful and sometimes dangerous psychotropic drugs. In many cases, these drugs were not necessary and over-prescribed. The children were being systematically medicated due to the mandated use of a program that was designed by "expert consultants" who were also paid consultants for the pharmaceutical industry.

    Tags: psychotropic drugs; foster children; Texas Medical Director; antidepressants; Paxil; Texas Child Welfare System; Federal Medicaid Program

    By Nanci Wilson;Librado Lozano;Sara Robertson

    KEYE-TV (Austin, TX)

    2004

  • Drug Danger Cover-up? Evidence of Suppressed Information

    In a six month investigation of the antidepressant manufacturers, PrimeTime Live uncovered a trail of internal documentation revealing efforts to suppress information regarding serious adverse health risks from consumers and the doctors who prescribe these powerful psychoactive medications. Patients, and parents of juvenile patients, suspected that the drug companies were not coming clean about the negative effects of antidepressants.

    Tags: antidepressants; psychoactive medication; suicidal behavior in children; Glaxo SmithKline; Paxil; Vioxx; Wyeth; Effexor; Pfizer; Zoloft

    By Chris Cuomo;Shelley Ross;Chris Vlasto;Greg Fisher;Kate Sheekey;Kim Launier;Asa Eslocker;Faith Jones;Ed Delgado

    ABC News Primetime Live

    2004

  • Inside the happiness business

    New York reports on the aggressive marketing of drugs, and antidepressants in particular. The story looks at the techniques used by drug sales representatives to attract doctors' attention to the new medications available on the market. The promotion strategies - including free lunches, vacations and gifts - have convinced many doctors to start prescribing a new drug despite some evidence of potential side effects, the investigation reveals. The article focuses on the sales of the newest antidepressant in the U.S.A., Celexa, originally developed by a small Danish company in 1972. The reporter points to the concerns of Dr. Robert Goodman who has started a 'no-free-lunch' campaign against the practices of the drug sales reps.

    Tags: Prozac; Zoloft; Paxil; health; doctors; patients; psychiatry; corruption; Pfizer; FDA; depression; weight gain; American Psychiatric Association

    By David D. Kirkpatrick

    New York

    2000

  • Druging our CHildren

    Using the PharmaNet patient information database, reporter Ann Rees found that children, from infants to teenagers were receiving quite a bit of "mood" drugs including tranquilizers, stimulatns, uppers, downers, anti-depressants, anti-pshychotic mediations, Prozac, sedatives. The findings are based on data for all patients under the age of 20 in British Columbia.

    Tags: Ritalin; pediatrics; prescriptions; psychiatric drug use; pediatric children; Paxil; Risperidone; CAR; FOI

    By Ann Rees

    PRovince (Vancouver, B.C.)

    2000

  • Selling Shyness

    According to a recent study, one in eight Americans are socially phobic. The New Republic examines how this epidemic of social phobia was fostered by an expanded definition of the disorder and a push from drug companies who stand to make a big profit from new medications such as Paxil.

    Tags: Drugs

    By Michelle Cottle

    New Republic

    1999